Executive Overview In a significant strategic expansion of its oncology clinical development pipeline, Summit Therapeutics has announced the initiation of...
Executive Overview In a significant milestone for modern oncology and the evolution of cell-based immunotherapies, clinical-stage biopharmaceutical company Dispatch Bio...
Executive Overview In the high-stakes world of biopharmaceutical research, the line separating scientific innovation from investor skepticism is razor-thin. On...
Executive Overview In a decisive move emblematic of the hyper-selective, risk-averse climate currently dominating the biotech sector, Philadelphia-based Context Therapeutics...
Executive Overview The global clinical trials landscape is undergoing a structural realignment, with the People’s Republic of China firmly anchoring...
Executive Overview In a major development for the clinical advancement of genetic medicines targeting rare muscle disorders, biotechnology innovator PepGen...
Executive Overview In a significant development for the global oncology landscape, pharmaceutical giants MSD (known as Merck & Co. in...
Executive Overview In a monumental step forward for global health security, biotechnology pioneer Moderna has officially dosed its first participants...
Executive Overview In a significant milestone for modern oncology and targeted drug delivery, biopharmaceutical innovator SystImmune has officially dosed the...
Executive Overview In the high-stakes arena of modern oncology, time is the ultimate currency. For brain cancer patients navigating the...